Perturbed 6-Tetrahydrobiopterin Recycling via Decreased Dihydropteridine Reductase in Vitiligo: More Evidence for H2O2 Stress

Journal of Investigative Dermatology

Volumn 122, Issue 2, 2004, Pages 307-313

  Hasse, Sybille ^a   Gibbons, Nicholas C J ^a   Rokos, Hartmut ^a   Marles, Lee K ^a   Schallreuter, Karin U ^a,b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Oxidative stress; Reactive oxygen species; Vitiligo

Indexed keywords

CATALASE; DIHYDROPTERIDINE REDUCTASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROLYASE; METHIONINE SULFOXIDE; NITRIC OXIDE SYNTHASE; OXYGENASE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; EPIDERMIS; FEMALE; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; LYMPHOCYTE; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; RECYCLING; STRESS; VITILIGO;

EID: 1442274600     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2004.22230.x     Document Type: Article

References (46)

1. Arai N, Narisawa K, Hayakawa H, Tada K: Hyperphenylalaninemia due to dihydropteridine reductase deficiency: Diagnosis by enzyme assays on dried blood spots. Pediatrics 70:426-430, 1982
2. Aronoff S: Catalase: Kinetics of photo-oxidation. Science 150:72-73, 1965
3. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU: Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 141:301-303, 1999
4. Davis MD, Ribeiro P, Tipper J, Kaufman S: "7-tetrahydrobiopterin, " a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. Proc Natl Acad Sci USA 89:10109-10113, 1992
5. Dell'Anna ML, Maresca V, Briganti S, Camera E, Falchi M, Picardo M: Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 117:908-913, 2001
6. Firgaira FA, Choo KH, Cotton RG, Danks DM: Heterogeneity of the molecular defect in human dihydropteridine reductase deficiency. Biochem J 198:677-682, 1981
7. Firgaira FA, Cotton RG, Danks DM: Dihydropteridine reductase deficiency diagnosis by assays on dried peripheral blood-cells. Lancet 15:1260-1263, 1979
8. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF: Photomedicine. In: Dermatology in General Medicine. New York: McGraw-Hill, 1971; p 1692-1695
9. Friedman PA, Kappelman AH, Kaufman S: Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem 247:4165-4173, 1972
10. Gibson A, Lilley E: Superoxide anions, free radical scavengers, and nitrergic neurotransmission. Gen Pharmacol 28:489-493, 1997
11. Hasegawa H, Nakanishi N: Dihydropteridine reductase from bovine liver. Methods Enzymol 142:103-111, 1987
12. Jimbow K, Chen H, Park JS, Thomas PD: Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55-65, 2001
13. Kaufman S, Fisher DB: Pterin-requiring aromatic amino acid hydroxylases. In: Hayaishi O (ed). Molecular Mechanisms of Oxygen Activation. New York: Academic Press, 1974; p 285-369
14. Kaufman S: Tetrahydrobiopterin: Basic Biochemistry and Role in Human Disease. Baltimore: John Hopkins University Press, 1997; p 448
15. Kowlessur D, Citron BA, Kaufman S: Recombinant human phenylalanine hydroxylase: Novel regulatory and structural properties. Arch Biochem Biophys 333:85-95, 1996
16. Maresca V, Roccella M, Roccella F, et al : Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 109:310-313, 1997
17. Maries LK, Peters EM, Tobin DJ, Hibberts NA, Schallreuter KU: Tyrosine hydroxylase isoenzyme 1 is present in human melanosomes: A possible novel function in pigmentation. Exp Dermatol 12:61-70, 2003
18. 2-mediated oxidation of tetrahydrobiopterin: FT Raman Investigations provide mechanistic implications for the enzymatic utilisation and recycling of this essential cofactor. J Raman Spectrosc 33:610-617, 2002
19. Nagatsu T, Levitt M, Udenfriend S: Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. Biochem Biophys Res Commun 14:543-549, 1964
20. Narisawa K, Arai N, Hayakawa H, Tada K: Diagnosis of dihydropteridine reductase deficiency by erythrocyte enzyme assay. Pediatrics 68:591-592, 1981
21. Narisawa K, Arai N, Ishizawa Y, Ogasawara A, Onuma KI, Tada K: Dihydropteridine reductase deficiency: Diagnosis by leucocyte enzyme assay. Clin Chim Acta 105:335-342, 1980
22. Ortonne JP, Bose SK: Vitiligo: Where do we stand? Pigment Cell Res 6:61-72, 1993
23. Passi S, Grandinetti M, Maggio F, De Stancato A, Luca C: Epidermal oxidative stress in vitiligo. Pigment Cell Res 11:81-85, 1998
24. Pittelkow MR, Shipley GD: Serum-free culture of normal human melanocytes: Growth kinetics and growth factor requirements. J Cell Physiol 140:565-576, 1989
25. 2 and pterin-6-carboxylic acid. Biochem Biophys Res Commun 292:805-811, 2002
26. Schallreuter KU: Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 12:132-138, 1999
27. Schallreuter KU, Büttner G, Pittelkow MR, Wood JM, Swanson NN, Körner C: Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun 204:43-48, 1994a
28. Schallreuter KU, Lemke KR, Pittelkow MR, Wood JM, Körner C, Malik R: Catecholamines in human keratinocyte differentiation. J Invest Dermatol 104:953-957, 1995a
29. Schallreuter KU, Moore J, Behrens-Williams SC, Panske A, Harari M: Rapid initiation in vitiligo with Dead Sea climatotherapy in combination with pseuocatalase (PC-KUS). Int J Dermatol 41:482-487, 2002b
30. Schallreuter KU, Moore J, Behrens-Williams SC, Panske A, Harari M, Rokos H, Wood JM: In vitro and in vivo identification of pseudocatalase activity in Dead Sea water using FT Raman spectroscopy. J Raman Spectrosc 33:586-592, 2002a
31. 4-dependent processes? J Invest Dermatol 116:167-174, 2001
32. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc 4:91-96, 1999
33. Schallreuter KU, Wood JM, Berger J: Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97:1081-1085, 1991
34. Schallreuter KU, Wood JM, Lemke R, et al : Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 189:72-78, 1992
35. Schallreuter KU, Wood JM, Lemke KR, Levenig C: Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: A case study on 33 patients. Dermatology 190:223-229, 1995b
36. Schallreuter KU, Wood JM, Pittelkow MR, et al : Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263:1444-1446, 1994b
37. Schallreuter KU, Wood JM, Pittelkow MR, Büttner G, Swanson N, Körner C, Ehrke C: Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res 288:14-18, 1996
38. Schallreuter KU, Wood JM, Ziegler I, et al : Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1226:181-192, 1994c
39. Schallreuter KU, Zschiesche M, Moore J, et al : In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun 243:395-399, 1998
40. Shimizu Y, Sakai M, Umemura Y, Ueda H: Immunohistochemical localization of nitric oxide synthase in normal human skin: Expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J Dermatol 24:80-87, 1997
41. Slominski A, Pisarchik A, Semak I, et al : Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16:896-898, 2002
42. Slominski A, Wortsman J: Neuroendocrinology of the skin. Endocr Rev 21:457-487, 2000
43. Thöny B, Auerbach G, Blau N: Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347:1-16, 2000
44. Varughese KI, Skinner MM, Whiteley JM, Matthews DA, Xuong NH: Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci USA 89:6080-6084, 1992
45. Varughese KI, Xuong NH, Kiefer PM, Matthews DA, Whiteley JM: Structural and mechanistic characteristics of dihydropteridine reductase: A member of the Tyr-(Xaa) 3-Lys-containing family of reductases and dehydrogenases. Proc Natl Acad Sci USA 91:5582-5586, 1994
46. Wille JJ, Pittelkow MR, Shipley GD, Scott RE: Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: Clonal analyses, growth kinetics and cell cycle studies. J Cell Physiol 121:31-44, 1984